Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui Peng

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Virology|February 15, 2005
DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replicationJean D Boyer, Tara M Robinson, Paulo C Maciag, et al.
Oncotarget|July 23, 2014
Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerChunsheng Li, Junying Wang, Jia Hu, et al.
Journal of Medicinal Chemistry|August 30, 2021
Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor ActivityJan Elsner, Dan Cashion, Dale Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.
Journal of Medicinal Chemistry|April 19, 2019
Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent EfficacyJennifer R Riggs, Jan Elsner, Dan Cashion, et al.
Science Advances|November 22, 2023
Rapidly determining the 3D structure of proteins by surface-enhanced Raman spectroscopyHao Ma, Sen Yan, Xinyu Lu, et al.
Nature Medicine|June 3, 2024
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final resultsChangsong Qi, Chang Liu, Jifang Gong, et al.
Nature Medicine|May 9, 2022
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim resultsChangsong Qi, Jifang Gong, Jian Li, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Virology|February 15, 2005
DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replicationJean D Boyer, Tara M Robinson, Paulo C Maciag, et al.
Oncotarget|July 23, 2014
Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerChunsheng Li, Junying Wang, Jia Hu, et al.
Journal of Medicinal Chemistry|August 30, 2021
Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor ActivityJan Elsner, Dan Cashion, Dale Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.
Journal of Medicinal Chemistry|April 19, 2019
Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent EfficacyJennifer R Riggs, Jan Elsner, Dan Cashion, et al.
Science Advances|November 22, 2023
Rapidly determining the 3D structure of proteins by surface-enhanced Raman spectroscopyHao Ma, Sen Yan, Xinyu Lu, et al.
Nature Medicine|June 3, 2024
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final resultsChangsong Qi, Chang Liu, Jifang Gong, et al.
Nature Medicine|May 9, 2022
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim resultsChangsong Qi, Jifang Gong, Jian Li, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 8